Search

everythinglearnresearchcommunity

for

Search:↓

Avoid high-tension styles and use professional treatments to reduce hair damage and health risks.

Three characteristics of plasmacytoid dendritic cells help tell apart lupus-related hair loss from LPP.

Trichoscopy helps tell apart Frontal Fibrosing Alopecia and Lichen planopilaris by showing different hair and scalp features.

Enzymes that change arginine to citrulline are important for skin barrier and hair formation, and their malfunction can lead to skin conditions and hair disorders.

Scalp biopsies greatly improved diagnosis and treatment for Black women with unclear alopecia.

Understanding the cause of bitemporal hair loss is key to deciding the right treatment.

Dermatologists often neglect hair disorders due to complexity and lack of clear treatments, impacting patient care and highlighting the need for better education and interest in this area.

Afro-textured hair is more fragile and prone to certain scalp conditions, requiring careful treatment and more research for effective management.

Significant progress has been made in treating skin, hair, and nail disorders in people with skin of color, but disparities still exist.

Early and accurate diagnosis of posterior scalp hair loss is crucial for effective treatment and better outcomes.

Alopecia causes hair loss and should be treated early, especially scarring types where hair cannot regrow.

Classifying curl patterns might help doctors assess and treat hair loss better.

A woman with CCCA has hair loss due to factors like straighteners and tight hairstyles, and treatments include steroids and avoiding certain hair products.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

The document explains hair and nail biology, common hair loss conditions and treatments, oral and genital skin diseases, and the risks and treatments associated with squamous cell carcinoma.

L'Oréal's research and workshops have advanced understanding and tailored cosmetics for African hair and skin.

TikTok can educate about alopecia, but more accurate content from medical professionals is needed.

Different types of alopecia cause hair loss due to immune system issues, with some allowing regrowth and others causing permanent loss.

Hesperidin may help reduce hair loss by protecting hair follicles.

Rosemary shows promise in treating alopecia, similar to minoxidil, but more research is needed.

Xtressé™ gummies may help increase hair growth in women, especially in early hair loss stages.

5-alpha reductase inhibitors and spironolactone don't increase gynecological tumor risk, glucagon-like-peptide-1 receptor agonists may increase alopecia risk, sanitary pads can cause dermatitis, early hidradenitis suppurativa intervention is crucial for Hispanic patients, community education boosts skin cancer awareness, metformin may improve skin cancer survival, LNG-IUDs can increase acne risk, machine learning accurately detects basal cell carcinoma, JAK-inhibitors may raise miscarriage risk, inclusive skincare ads affect those with darker skin, and CCCA in Black women might involve autoimmunity.

People with primary scarring alopecia have higher risks of other health issues like vitamin D deficiency and thyroid disease.

Bicalutamide can reduce female pattern hair loss, especially in those with certain conditions, but has limited effects on other hair loss types.

ChatGPT is more accurate at diagnosing hair disorders in lighter skin tones than darker ones.

The condition is harmless, doesn't worsen, and needs no invasive treatment.

COVID-19 may trigger hair loss in some people.

Minoxidil may help with hair regrowth and disease stabilization in scarring alopecia, but side effects vary, needing more research for consistent safety and effectiveness.

The document concludes that more local research on African skin and hair is needed despite increased scientific output from Sub-Saharan Africa.

Biopsies matched initial diagnoses in 76.6% of black women with alopecia and led to treatment changes in 44% of cases.